Effect of Nicorandil for the Patients of Acute ST Segment Elevation Myocardial Infarction
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.
Also called NCT02435797
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 100 participants
- Sponsor
- Xuzhou Central Hospital
- Registry
-
NCT02435797
-
- Other papers using this trial's data
- Effects of Early Intracoronary Administration of Nicorandil During Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT02435797. Randomized; single masking; primary purpose prevention. Start 2015-04 (registry gives no type); primary completion 2015-08 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effect of Nicorandil for the Patients of Acute ST Segment Elevation Myocardial Infarction
- Condition
- Coronary Heart Disease
- Intervention (Drug)
- Nicorandil
- Intervention (Drug)
- normal saline
- Lead sponsor
- Xuzhou Central Hospital
Record details
- Record id
cardio:ct-nct02435797- Content hash
15dc62252d33a58fe502c667b47224659b751e14b8b54061e7fc5f9d9ed12451